Manack相关文献与解析，生知库 | 链接生命科学的每一步

Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review

更正：阿托格泮联合A型肉毒杆菌毒素预防慢性偏头痛的真实世界安全性和有效性证据：一项回顾性病历审查

Blumenfeld, Andrew M; Mechtler, Laszlo; Cook, Lisa; Rhyne, Christopher; Jenkins, Brian; Hughes, Olivia; Dabruzzo, Brett; Manack Adams, Aubrey; Diamond, Merle

偏头痛

神经科学

发表日期：2025

文献求助收藏

Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study

偏头痛就医障碍特征分析：来自慢性偏头痛流行病学和结局国际研究（CaMEO-I）的多国结果

期刊:Journal of Headache and Pain

影响因子:7.9

doi:10.1186/s10194-024-01834-y

Lanteri-Minet, Michel; Leroux, Elizabeth; Katsarava, Zaza; Lipton, Richard B; Sakai, Fumihiko; Matharu, Manjit; Fanning, Kristina; Manack Adams, Aubrey; Sommer, Katherine; Seminerio, Michael; Buse, Dawn C

Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE

Ubrogepant联合抗降钙素基因相关肽单克隆抗体治疗偏头痛急性发作的真实世界应用：COURAGE研究结果

期刊:Neurology and Therapy

影响因子:4.8

doi:10.1007/s40120-023-00556-8

Lipton, Richard B; Contreras-De Lama, Janette; Serrano, Daniel; Engstrom, Ella; Ayasse, Nicolai D; Poh, Weijie; Cadiou, François; Manack Adams, Aubrey

Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review

阿托格泮联合A型肉毒杆菌毒素预防慢性偏头痛的安全性和有效性的真实世界证据：一项回顾性病例分析

期刊:Pain and Therapy

影响因子:3.3

doi:10.1007/s40122-024-00649-8

Blumenfeld, Andrew M; Mechtler, Laszlo; Cook, Lisa; Rhyne, Christopher; Jenkins, Brian; Hughes, Olivia; Dabruzzo, Brett; Manack Adams, Aubrey; Diamond, Merle

Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study

偏头痛发作前和发作后阶段：来自 CaMEO 国际研究的多国结果

期刊:Journal of Headache and Pain

影响因子:7.9

doi:10.1186/s10194-023-01683-1

Lipton, Richard B; Lanteri-Minet, Michel; Leroux, Elizabeth; Manack Adams, Aubrey; Contreras-De Lama, Janette; Reed, Michael L; Fanning, Kristina M; Buse, Dawn C

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study

乌布罗格泮联合A型肉毒杆菌毒素治疗急性偏头痛的真实世界疗效、满意度和优化：COURAGE研究结果

期刊:Journal of Headache and Pain

影响因子:7.9

doi:10.1186/s10194-023-01622-0

Manack Adams, Aubrey; Hutchinson, Susan; Engstrom, Ella; Ayasse, Nicolai D; Serrano, Daniel; Davis, Linda; Sommer, Katherine; Contreras-De Lama, Janette; Lipton, Richard B

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review

多模式偏头痛管理与追求摆脱偏头痛：叙述性综述

期刊:Neurology and Therapy

影响因子:4.8

doi:10.1007/s40120-023-00529-x

Blumenfeld, Andrew M; Lipton, Richard B; Silberstein, Stephen; Tepper, Stewart J; Charleston, Larry 4th; Landy, Stephen; Kuruvilla, Deena E; Manack Adams, Aubrey

Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

优化急性偏头痛治疗与偏头痛患者更高的生产力相关：来自慢性偏头痛流行病学和结果 (CaMEO) 研究的结果

期刊:Journal of Occupational and Environmental Medicine

影响因子:1.4

doi:10.1097/JOM.0000000000002801

Buse, Dawn C; Nahas, Stephanie J; Stewart, Walter Buzz F; Armand, Cynthia E; Reed, Michael L; Fanning, Kristina M; Manack Adams, Aubrey; Lipton, Richard B

OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patients

A型肉毒杆菌毒素可改变慢性头痛患者的炎症基因表达和免疫细胞

期刊:Brain

影响因子:11.7

doi:10.1093/brain/awab461

Gfrerer, Lisa; Xu, Wenjie; Austen, William; Ashina, Sait; Melo-Carrillo, Agustin; Longhi, Maria Serena; Adams, Aubrey Manack; Houle, Timothy; Brin, Mitchell F; Burstein, Rami

Mapping Dural and Periosteal SV2C, a Botulinum Toxin A Receptor, in the Mouse.

在小鼠中绘制硬脑膜和骨膜 SV2C（肉毒杆菌毒素 A 受体）的分布图。

Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review

更正：阿托格泮联合A型肉毒杆菌毒素预防慢性偏头痛的真实世界安全性和有效性证据：一项回顾性病历审查

Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study

偏头痛就医障碍特征分析：来自慢性偏头痛流行病学和结局国际研究（CaMEO-I）的多国结果

Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE

Ubrogepant联合抗降钙素基因相关肽单克隆抗体治疗偏头痛急性发作的真实世界应用：COURAGE研究结果

Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review

阿托格泮联合A型肉毒杆菌毒素预防慢性偏头痛的安全性和有效性的真实世界证据：一项回顾性病例分析

Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study

偏头痛发作前和发作后阶段：来自 CaMEO 国际研究的多国结果

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study

乌布罗格泮联合A型肉毒杆菌毒素治疗急性偏头痛的真实世界疗效、满意度和优化：COURAGE研究结果

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review

多模式偏头痛管理与追求摆脱偏头痛：叙述性综述

Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

优化急性偏头痛治疗与偏头痛患者更高的生产力相关：来自慢性偏头痛流行病学和结果 (CaMEO) 研究的结果

OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patients

A型肉毒杆菌毒素可改变慢性头痛患者的炎症基因表达和免疫细胞